Shippers with complex needs and tight budgets are outsourcing more of their freight to managed transportation providers.

The bloc could move quickly by re-applying duties it first imposed on the U.S. during Trump’s first term. 

Join us for an exclusive conversation with Scott DeGroot, former VP of Global Planning at Kimberly-Clark (Now with the University of Tennessee), as he shares how he got support for innovative supply chain strategies to drive cost savings, improve efficiency, and enable reinvestment in advanced systems.

Can the U.S. pharmaceutical supply chain come home — or, at least, get closer to it?

Every stage of a healthcare product shipment, from the manufacturer to the supplier to the dock of the hospital, must be in a format that the hospital can work with.

The future contains much uncertainty, but also a wealth of opportunities for innovative and far-thinking enterprises. 

“Trump’s tariffs on Mexico and Canada will make your life more expensive,” Congressman Greg Stanton said in a post on X. 

Now, only companies with more than 1,000 employees and over €50 million ($52 million) in turnover will need to report on their carbon emissions.

Getting closer to customers has become a major priority for manufacturers that are looking to reduce transportation costs and delivery times. Expectations for faster delivery have risen thanks to the “Amazon effect.” Add in disruptions from recent years — the pandemic, geopolitical instability, extreme weather, trade issues, labor unrest — and you have a mandate for the increasing realignment of supply chains, production and sourcing.